HLB Therapeutics Co.,Ltd. (115450.KQ)
KRW 10680.0
(-2.11%)
KRW 10680.0
(-2.11%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 29.27 Billion KRW | -50.82% |
| 2022 | 59.52 Billion KRW | -0.24% |
| 2021 | 59.67 Billion KRW | 175.85% |
| 2020 | 21.63 Billion KRW | -65.89% |
| 2019 | 63.42 Billion KRW | 141.84% |
| 2018 | 26.22 Billion KRW | 40.25% |
| 2017 | 18.69 Billion KRW | 27.32% |
| 2016 | 14.68 Billion KRW | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 38.63 Billion KRW | 16.27% |
| 2024 Q1 | 33.22 Billion KRW | 13.51% |
| 2023 Q1 | 44.82 Billion KRW | -24.69% |
| 2023 Q4 | 29.27 Billion KRW | -15.24% |
| 2023 Q3 | 34.53 Billion KRW | -2.69% |
| 2023 Q2 | 35.49 Billion KRW | -20.83% |
| 2023 FY | 29.27 Billion KRW | -50.82% |
| 2022 Q3 | 71.31 Billion KRW | 6.69% |
| 2022 Q4 | 59.52 Billion KRW | -16.53% |
| 2022 Q1 | 61.86 Billion KRW | 3.67% |
| 2022 Q2 | 66.83 Billion KRW | 8.04% |
| 2021 Q3 | 24.32 Billion KRW | 0.0% |
| 2021 Q4 | 59.67 Billion KRW | 145.29% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| HLB Co., Ltd. | 169.47 Billion KRW | 82.726% |
| iNtRON Biotechnology, Inc. | 1.88 Billion KRW | -1456.934% |
| BINEX Co., Ltd. | 75.68 Billion KRW | 61.319% |
| Bioneer Corporation | 80.61 Billion KRW | 63.682% |
| Anterogen.Co.,Ltd. | 19.98 Billion KRW | -46.477% |
| MEDIPOST Co., Ltd. | 135.73 Billion KRW | 78.432% |
| CrystalGenomics, Inc. | 97.82 Billion USD | 70.072% |
| Helixmith Co., Ltd | 73.55 Billion KRW | 60.2% |
| Chabiotech Co.,Ltd. | 1069.23 Billion KRW | 97.262% |
| Medy-Tox Inc. | 137.14 Billion KRW | 78.653% |
| Peptron, Inc. | 16.36 Billion KRW | -78.851% |
| Amicogen, Inc. | 248.12 Billion KRW | 88.201% |
| Genexine, Inc. | 79.68 Billion KRW | 63.259% |
| LegoChem Biosciences, Inc. | 41.28 Billion KRW | 29.081% |
| ALTEOGEN Inc. | 108.25 Billion KRW | 72.957% |
| PharmaResearch Co., Ltd. | 73.08 Billion KRW | 59.943% |
| SillaJen, Inc. | 19.4 Billion KRW | -50.9% |
| JETEMA, Co., Ltd. | 179.09 Billion KRW | 83.653% |
| OliX Pharmaceuticals,Inc | 52.48 Billion KRW | 44.225% |
| Genomictree Inc. | 7.81 Billion KRW | -274.744% |
| MedPacto, Inc. | 9.56 Billion KRW | -206.051% |
| D&D Pharmatech | 23.98 Billion KRW | -22.056% |
| EASY BIO,Inc. | 105.86 Billion KRW | 72.347% |
| GI Innovation, Inc. | 9.63 Billion KRW | -203.813% |